985-16-0
985-16-0
Chemical Structure
Nafcillin sodium
- CAS No.: 985-16-0
- Formula:C21H21N2NaO5S
- Molecular Weight:436.46
IUPAC Name: sodium (2S,5R,6R)-6-(2-ethoxy-1-naphthamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
InChIKey: AYAPZOUDXCDGIF-FRFVDRIFSA-M
SMILES: O=C([C@@H]1N(C2=O)[C@]([C@@H]2NC(C(C3=CC=CC=C3C=C4)=C4OCC)=O)([H])SC1(C)C)O[Na]
Biological Activity: Nafcillin sodium, an antibiotic, is a reversible inhibitor of β-lactamase. Nafcillin sodium can be used for the research of staphylococcal infections[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Nafcillin sodium | Nafcillin sodium, an antibiotic, is a reversible inhibitor of β-lactamase. Nafcillin sodium can be used for the research of staphylococcal infections. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Nafcillin-d5 sodium | 98.04% | Nafcillin-d5 (sodium) is the deuterium labeled Nafcillin sodium. Nafcillin sodium, an antibiotic, is a reversible inhibitor of β-lactamase. Nafcillin sodium can be used for the research of staphylococcal infections. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.82
HY-B0555ARNafcillin sodium monohydrate (Standard) -
Similarity Score 0.75
HY-B0555Nafcillin -
Similarity Score 0.65
HY-B0974Methicillin sodium salt -
Similarity Score 0.65
HY-121544ARMethicillin sodium hydrate (Standard) -
Similarity Score 0.60
HY-122362Carfecillin sodium -
Similarity Score 0.60
HY-121544Methicillin -
Similarity Score 0.59
HY-137945Phenethicillin sodium -
Similarity Score 0.59
HY-N14699Diphenicillin -
Similarity Score 0.59
HY-B0522ARAmpicillin sodium (Standard) -
Explore the MedChemAI to find more analogs
References
- [1]. Tan AK, et, al. Identification of the site of covalent attachment of nafcillin, a reversible suicide inhibitor of beta-lactamase. Biochem J. 1992 Jan 1;281 ( Pt 1)(Pt 1):191-6. [Content Brief]
- [2]. Palmer DL, et, al. Bacterial wound colonization after broad-spectrum versus narrow-spectrum antibiotics. Ann Thorac Surg. 1995 Mar;59(3):626-31. [Content Brief]
